Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Short term Debt (2016 - 2024)

Sanara MedTech (SMTI) has disclosed Short term Debt for 11 consecutive years, with $928571.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Short term Debt changed N/A year-over-year to $928571.0, compared with a TTM value of $928571.0 through Mar 2024, changed N/A, and an annual FY2023 reading of $580357.0, changed N/A over the prior year.
  • Short term Debt was $928571.0 for Q1 2024 at Sanara MedTech, up from $580357.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $928571.0 in Q1 2024 and bottomed at $114975.0 in Q3 2020.
  • Average Short term Debt over 3 years is $409295.8, with a median of $232143.0 recorded in 2023.
  • Peak annual rise in Short term Debt hit 80.96% in 2020, while the deepest fall reached 94.25% in 2020.
  • Year by year, Short term Debt stood at $114975.0 in 2020, then skyrocketed by 404.77% to $580357.0 in 2023, then soared by 60.0% to $928571.0 in 2024.
  • Business Quant data shows Short term Debt for SMTI at $928571.0 in Q1 2024, $580357.0 in Q4 2023, and $232143.0 in Q3 2023.